Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?

K. Borg (Oxford, United Kingdom)

Source: International Congress 2017 – Airway disease and exacerbations
Session: Airway disease and exacerbations
Session type: Thematic Poster
Number: 1126
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Borg (Oxford, United Kingdom). Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?. 1126

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 596s
Year: 2004

Inflammation and diagnosis of asthma: exhaled nitric oxide (FENO) and induced sputum eosinophil count
Source: Eur Respir J 2005; 26: Suppl. 49, 280s
Year: 2005

Relationship of peripheral eosinophil count in patients with asthma to weight, pulmonary function tests, and exhaled nitric oxide.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Discordance between sputum eosinophil counts and exhaled nitric oxide levels in asthma
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA)
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Sputum inflammatory biomarkers and exhaled nitric oxide (FENO) in varying severity asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Does exhaled nitric oxide and blood eosinophil count correlate in phenotypes of severe and brittle asthma?
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Sputum neutrophilia is correlated with levels of exhaled nitric oxide (NO) in patients with chronic, stable sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 344s
Year: 2001

Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003

Associations between blood eosinophils and markers of nitric oxide pathway in blood and in exhaled breath condensate in asthmatics from the EGEA study
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010


Correlation of exhaled nitric oxide with IgE levels and eosinophils in blood in pediatric asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Exhaled nitric oxide threshold to predict sputum eosinophils count ≥3% in a cohort of unselected asthmatics
Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma
Year: 2009


The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004

Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Exhaled nitric oxide and blood eosinophilia: biomarkers of different adult asthma phenotypes
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008

Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002

Evaluation of exhaled nitric oxide and sputum eosinophils as markers of inflammation in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003